Incyte (INCY) Tops Q1 EPS by 4c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/24/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Incyte (INCY) PT Raised to $146 at BMO Capital
May 5, 2017 9:13 AM EDTBMO Capital raised its price target on Incyte (NASDAQ: INCY) to $146.00 (from $144.00) while maintaining a Outperform rating following strong Jakafi results in Q1.
Analyst M. Ian Somaiya commented, "While polycythemia vera (PV) continues to be a growth driver, graft vs host... More



